medac GmbH
Quick facts
Marketed products
- recombinant asparaginase · Oncology
Recombinant asparaginase depletes the amino acid asparagine from the bloodstream, starving asparagine-dependent leukemic cells of an essential nutrient required for protein synthesis.
Phase 3 pipeline
- MC0518 · Oncology
MC0518 is a histone deacetylase (HDAC) inhibitor that promotes differentiation and apoptosis of myelodysplastic syndrome cells. - methotrexate prefilled pen
- methotrexate prefilled syringe · Oncology, Autoimmune diseases
Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, disrupting DNA synthesis and cell division.
Phase 2 pipeline
- Busilvex · Oncology
- Spectrila®
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: